The authors established FOXO4-DRI as a first-in-class senolytic peptide tool for cellular senescence research, with mechanistic selectivity grounded in the elevated FOXO4-p53 interaction in senescent versus non-senescent cells
However, it is more accurately described as a bonding hormone, facilitating not only interpersonal connections but also associations with memories and brain regions, potentially aiding access to different neural pathways
BPC-157 is a pentadecapeptide derived from a gastric protein fragment, while TB-500 is a synthetic analog of thymosin beta-4 associated with actin-binding dynamics and peptide-mediated cellular processes
Other common therapies that have been tried as alternatives include exercise, glucosamine, omega-3 fatty acids, collagen, pain medication and, more recently, peptides